| Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era G Goyal, ML Heaney, M Collin, F Cohen-Aubart, A Vaglio, BH Durham, ... Blood, The Journal of the American Society of Hematology 135 (22), 1929-1945, 2020 | 264 | 2020 |
| Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells O Hershkovitz Rokah, G Granot, A Ovcharenko, S Modai, ... PloS one 7 (4), e35501, 2012 | 123 | 2012 |
| Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects O Hershkovitz‐Rokah, D Pulver, G Lenz, O Shpilberg British journal of haematology 181 (3), 306-319, 2018 | 92 | 2018 |
| MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein O Hershkovitz-Rokah, S Modai, M Pasmanik-Chor, A Toren, N Shomron, ... Cancer letters 356 (2), 597-605, 2015 | 80 | 2015 |
| Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment O Hershkovitz-Rokah, S Modai, M Pasmanik-Chor, A Toren, N Shomron, ... Cancer letters 360 (2), 245-256, 2015 | 68 | 2015 |
| NAD (P) H quinone oxidoreductase protects TAp63γ from proteasomal degradation and regulates TAp63γ-dependent growth arrest O Hershkovitz Rokah, O Shpilberg, G Granot PloS one 5 (6), e11401, 2010 | 29 | 2010 |
| Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas O Hershkovitz-Rokah, P Geva, M Salmon-Divon, O Shpilberg, ... Oncotarget 9 (8), 7928, 2018 | 20 | 2018 |
| Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim–Chester disease patients following BRAF inhibitor monotherapy RD Mazor, R Weissman, J Luckman, L Domachevsky, EL Diamond, ... Neuro-Oncology Advances 2 (1), vdaa024, 2020 | 19 | 2020 |
| Enhanced adhesion/migration and induction of Pyk2 expression in K562 cells following imatinib exposure A Ovcharenko, G Granot, OH Rokah, J Park, O Shpilberg, P Raanani Leukemia Research 37 (12), 1729-1736, 2013 | 9 | 2013 |
| Non-coding RNAs in normal B-cell development and in mantle cell lymphoma: from molecular mechanism to biomarker and therapeutic agent potential O Kersy, M Salmon-Divon, O Shpilberg, O Hershkovitz-Rokah International Journal of Molecular Sciences 22 (17), 9490, 2021 | 7 | 2021 |
| MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis R Weissman, EL Diamond, J Haroche, BH Durham, F Cohen, J Buthorn, ... Leukemia 36 (4), 1139-1149, 2022 | 5 | 2022 |
| The contribution of microRNAs to the inflammatory and neoplastic characteristics of erdheim–chester disease R Weissman, EL Diamond, J Haroche, N Pillar, G Shapira, BH Durham, ... Cancers 12 (11), 3240, 2020 | 5 | 2020 |
| Do pre-surgery eating habits affect weight loss one year following a sleeve gastrectomy? S Susmallian, A Raziel, I Nikiforova, S Sherf-Dagan, O Hershkovitz-Rokah, ... Clinical Nutrition ESPEN 19, 64-69, 2017 | 5 | 2017 |
| Expedient synthesis and anticancer evaluation of dual‐action 9‐anilinoacridine methyl triazene chimeras D Walunj, K Egarmina, H Tuchinsky, O Shpilberg, O Hershkovitz‐Rokah, ... Chemical Biology & Drug Design 97 (2), 237-252, 2021 | 4 | 2021 |
| Overcoming barriers to tumor genomic profiling through direct-to-patient outreach SA Doe-Tetteh, SY Camp, D Reales, J Crowdis, AM Noronha, B Wolff, ... Clinical Cancer Research 29 (13), 2445-2455, 2023 | 3 | 2023 |
| Inhibition of MAPK-ERK signaling pathway overcomes microrna-mediated ibrutinib resistance in mantle cell lymphoma O Kersy, M Salmon-Divon, M Gomes da Silva, AF Moita, J Cabecadas, ... Blood 140 (Supplement 1), 3109-3110, 2022 | 3 | 2022 |
| Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy JS Friedman, BH Durham, AS Reiner, M Yabe, K Petrova‐Drus, A Dogan, ... British Journal of Haematology, 2024 | 1 | 2024 |
| Deciphering the epigenetic landscape in histiocytic neoplasms M Salmon-Divon, R Meyuchas, J Benhamida, O Shpilberg, RD Mazor, ... Blood 142, 1161, 2023 | 1 | 2023 |
| AL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti‐apoptotic BCL2 family members H Fishov, E Muchtar, M Salmon‐Divon, A Dispenzieri, T Zvida, ... Cancer medicine 12 (7), 8199-8210, 2023 | 1 | 2023 |
| Efficacy of alpelisib in PI3K-driven Langerhans cell histiocytosis RD Mazor, BH Durham, OI Abdel-Wahab, EL Diamond, M Yabe, G Itchaki, ... PEDIATRIC BLOOD & CANCER 70, S31-S32, 2023 | 1 | 2023 |
